Macquarie tips substantial upside for Steadfast shares

Steadfast is a high-quality business at an attractive valuation, according to the broker.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Steadfast Group Ltd (ASX: SDF) shares have risen 76% over the past 5 years, handily beating the S&P/ASX 200 Index (ASX: XJO), which is up 42% over the same timeframe. 

Steadfast is Australia's largest general insurance broker and underwriting agency network. It focuses on small to medium enterprise (SME) businesses, which require the expertise of insurance brokers and agencies to assess and manage their commercial risks.

The ASX 200 insurance broker operates in a large and growing market. According to Grand View Research, the global insurance brokerage market was valued at US$287 billion in 2023. The North American market accounted for around 30% of this total. 

The global market is projected to grow at a compound annual growth rate of 9.2% between 2024 and 2030 to reach US$524 billion. This is likely to be driven by rising demand for insurance products as businesses face more frequent and severe catastrophic events.

Steadfast has a track record of expansion through strategic acquisitions. In 2024, it acquired 48 brokerage and underwriting agency businesses. This included ISU Group, a major network of independent agencies in the US, and Sure Insurance, a specialised underwriting agency. 

The insurance brokerage sector is highly fragmented. Its major competitor in Australia is AUB Group Ltd (ASX: AUB). In the US, it competes with the likes of Brown & Brown (NYSE: BRO) and Arthur J. Gallagher & Co (NYSE: AJG), which enjoy premium valuation multiples. 

Evidently, Steadfast has a lot going for it that could make it a much bigger business in the future.

But is it a good investment today?

Let's see what one broker had to say.

Business meeting to discuss buy now pay later platform

Image Source: Getty Images

Macquarie tips Steadfast to outperform

In a 3 July research note, broker Macquarie Group (ASX: MQG) reiterated its outperform rating on Steadfast shares. 

The broker has assigned a price target of $7.00 to the company. On Friday, Steadfast shares finished the trading session at $6.00. This suggests more than 20% upside from here, including both capital gains and dividends (Steadfast currently offers a dividend yield of 3.03%). 

When issuing this recommendation, the broker said:

Outperform. The ability to maximise returns on a US roll-out is key to SDF's long-term value. At current valuations, we retain our Outperform recommendation.

On the subject of valuation, Macquarie said Steadfast shares were currently very attractively valued relative to its international peers:

2-year forward PE multiple relative to international brokers: SDF is trading at a ~20.8% discount (vs a 2.3% long-term premium) to international brokers.

On the home front, the broker noted that it was trading at a premium relative to AUB, however, the gap had significantly narrowed from its historical levels:

2-year forward PE Rel SDF vs AUB: SDF is trading at a ~4.8% premium to AUB (compared with the ~11.6% long-term premium).

Foolish Takeaway

At a time when the ASX 200 is just below its all-time high, it may be challenging for investors to find quality businesses at attractive prices. Macquarie considers Steadfast shares to have an especially compelling valuation today.

Steadfast will release its full-year results for FY25 on 21 August. Stay tuned.

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Steadfast Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Arthur J. Gallagher & Co. The Motley Fool Australia has positions in and has recommended Macquarie Group and Steadfast Group. The Motley Fool Australia has recommended Aub Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Broker Notes

Why a top broker just downgraded this ASX 300 share

Bell Potter is no longer bullish on the stock. Let's find out why.

Read more »

A white EV car and an electric vehicle pump with green highlighted swirls representing ASX lithium shares
Broker Notes

Up 473% in a year, should I buy PLS shares today?

PLS – formerly Pilbara Minerals – leads the ASX 200’s top one-year gains board. But can the ASX lithium stock…

Read more »

Researchers and doctors with futuristic 3D hologram overlay for body anatomy or DNA in hospital clinic.
Broker Notes

Why 4DMedical shares can return to record highs: Expert

Why it could be an ideal time to buy the dip on this exciting stock.

Read more »

A child covering his eyes hiding from a toy bear.
Broker Notes

Brokers rate these 5 ASX 200 shares as a sell!

Find out why brokers are so bearish about these ASX 200 shares.

Read more »

A woman looks at a tablet device while in the aisles of a hardware style store amid stacked boxes on shelves representing Bunnings and the Wesfarmers share price
Broker Notes

Wesfarmers shares: Buy, hold or sell?

Two leading analysts offer their outlooks for Wesfarmers shares.

Read more »

Three young people in business attire sit around a desk and discuss.
Broker Notes

Buy, hold, sell: Origin Energy, Megaport, NAB shares

We review three new buy, hold, and sell calls from expert market analysts.

Read more »

Time to sell written on a clock.
Broker Notes

3 ASX 200 shares to sell this week according to experts

Experts are calling time on these shares.

Read more »

Woman on her laptop thinking to herself.
Broker Notes

Buy, hold, sell: Wesfarmers, Saluda Medical, CBA shares

Let's take a look at three new buy, hold, and sell recommendations from the experts.

Read more »